Seminar September 12, 2016

2016 IPO Annual Meeting

Event Detail
September 12, 2016
New York, NY
Patents for software and diagnostic methods are now subject to increased scrutiny under § 101, § 112(a), and § 112(b), both in the courts and at the USPTO. Dave Easwaran was an invited speaker on a panel that summarized how the developments in each of these areas affect the use of functional claim language.

The panelists provided an overview of changes in the determinations of patent eligibility, written description, enablement, definiteness, and means-plus-function interpretation, and outlined a series of best practices for patent drafting, prosecution, and portfolio management that address the more thorough evaluation that functional claims are likely to face in the future.

For more information, please click here .

September 12, 2016
New York Hilton Hotel / New York, NY

Media Contacts
Nicholas Clarke
Senior Communications Manager
Phone: 212.210.1222
This website uses cookies to improve functionality and performance. By continuing to browse this site, you are consenting to the use of cookies on this website. For details, see our Privacy Statement